Dr. Hilary Cass, independent pediatrician, speaks about the publication of the Independent Review of Gender Identity Services for Children and Young People (The Cass Review) in west London, on April 9, 2024. Yui Mok/PA WirePrescribing cross-sex hormones to 16 and 17-year-olds has been paused in the UK after a review by national health authorities found that evidence does not support their use.Masculinizing or feminizing hormones have been available for over a decade for young people aged 16-18 with a diagnosis of gender dysphoria who meet certain criteria, but all new referrals have been paused since March 9.
UK Pauses Prescribing Cross-Sex Hormones to Children Following Review
Date:
